Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI 48202, USA.
BJU Int. 2012 Aug;110(4):580-5. doi: 10.1111/j.1464-410X.2011.10786.x. Epub 2011 Dec 16.
Study Type - Therapy (case series). Level of Evidence 4 What's known on the subject? and What does the study add? • Initial reports of percutaneous suprapubic tube (PST) drainage following RARP demonstrated feasibility and short-term safety, while decreasing patient discomfort and utilization of anti-cholinergic medication. • This study demonstrates the long-term safety and efficacy of bladder drainage by PST; splinting the urethrovesical anastomosis is simply not essential if mucosal apposition is ensured.
• To evaluate the long-term safety and functional outcomes of patients undergoing percutaneous suprapubic tube (PST) drainage after robot-assisted radical prostatectomy (RARP).
• Between January 2008 and October 2009, 339 patients undergoing RARP by one surgeon experienced in RA surgery (M.M.) had postoperative bladder drainage with PST and a minimum of 1-year follow-up for urinary function. • Functional outcomes were obtained via patient-administered questionnaire. • Complications were captured by exhaustive review of multiple datasets, including our prospective prostate cancer database, claims data, as well as electronic medical and institutional morbidity and mortality records.
• Urinary function assessed by patient-administered questionnaire was analysed at a mean (sd) follow-up of 11.5 (1.7) months; after RARP with PST placement, 293 patients (86.4%) had total urinary control and only nine (2.7%) required >1 pad/day. • In all, 86 patients (25.4%) never wore a pad; the median time to 0-1 pad/day was 2 weeks (interquartile range [IQR] 0,6); median time to total control was 6 weeks (IQR 1,22). • The mean (sd) follow-up for complications was 23.7 (6.1) months. In all, 15 patients (4.4%) had a procedure-specific complication, of which 13 were minor (Clavien Class I/II 3.8%); one patient had a bladder neck contracture. • In all, 16 patients (4.7%) required Foley placement after RARP for gross haematuria (two patients), urinary retention (three), tube malfunction (four) or need for prolonged Foley catheterization (seven).
• PST placement after RARP is safe and efficacious on long-term follow-up. • Splinting of the urethrovesical anastomosis is not a critical step of RP if a watertight anastomosis and excellent mucosal apposition are achieved.
• 评估接受机器人辅助根治性前列腺切除术(RARP)后经皮耻骨上管(PST)引流的患者的长期安全性和功能结果。
• 2008 年 1 月至 2009 年 10 月,由一位在 RA 手术方面经验丰富的外科医生(M.M.)进行的 339 例 RARP 术后患者接受 PST 进行术后膀胱引流,并进行了至少 1 年的尿功能随访。• 通过患者管理的问卷获得功能结果。• 通过详尽的审查多个数据集(包括我们的前瞻性前列腺癌数据库、索赔数据以及电子医疗和机构发病率和死亡率记录)来捕获并发症。
• 通过患者管理的问卷评估尿功能,平均(sd)随访时间为 11.5(1.7)个月;在接受 RARP 联合 PST 置入后,293 例患者(86.4%)有完全的尿控能力,仅 9 例(2.7%)需要>1 片/天。• 总共 86 例患者(25.4%)从未使用过尿垫;从 0-1 片/天到无垫的中位时间为 2 周(四分位间距[IQR]0,6);从完全控制到无垫的中位时间为 6 周(IQR 1,22)。• 并发症的平均(sd)随访时间为 23.7(6.1)个月。总共 15 例患者(4.4%)发生了特定于手术的并发症,其中 13 例为轻度(Clavien 分类 I/II 3.8%);1 例发生膀胱颈挛缩。• 总共 16 例患者(4.7%)在 RARP 后因肉眼血尿(2 例)、尿潴留(3 例)、导管故障(4 例)或需要长时间留置 Foley 导管(7 例)而需要放置 Foley 导管。
• PST 放置在 RARP 后在长期随访中是安全有效的。• 如果实现了尿道膀胱吻合口的密闭性和良好的黏膜贴合,则吻合口的支架固定不是 RP 的关键步骤。